Skip to Main Content

36 New Programs and 23 Expanded Programs

Paul Taheri, MD, MBA
Photo by Robert A. Lisak

Paul Taheri, MD, MBA , Deputy Dean for Clinical Affairs and CEO, Yale Medical Group

All told, YCCI has developed 36 new programs and strategic initiatives that didn’t exist prior to the CTSA and made major investments that have expanded or enhanced the resources of 23 additional programs that span the institution. These initiatives have vastly changed the clinical and translational research landscape at Yale and across the entire Yale New Haven Health System.